Skip to main content

Sera Prognostics, Inc.

corporate_fare Company Profile

Sera Prognostics, Inc.

SERA·NASDAQ·Industrial Applications And Services·CIK 0001534969

The company is a women's health company that uses its proprietary proteomics and bioinformatics platform and extensive data resources to improve maternal and neonatal health. It achieves this by discovering, developing, and selling blood-based biomarker tests and predictive analytic products and services. The company aims to provide crucial and actionable information to pregnant women, their doctors, and healthcare payers to enhance the pregnancy experience, improve health outcomes for mothers and newborns, and lower healthcare costs. The company combines proteomics and bioinformatics with thorough clinical testing, data, and economic analysis. This approach allows it to offer personalized, clinically relevant, and economically beneficial information to improve pregnancy outcomes. Globally, there are approximately 140 million births each year, with about 3.7 million births annually in the United States. An estimated 30% of these pregnancies are affected by complications such as preterm birth, preeclampsia, fetal growth restriction, stillbirth, hypertension of pregnancy, and gestational diabetes. The company believes that current methods for predicting adverse pregnancy outcomes are inadequate for timely and effective management of most high-risk pregnancies. Preterm birth is a significant health risk in the U.S., contributing to approximately 34% of newborn deaths. The 2025 March of Dimes Report Card gave the United States a D+ grade for preterm birth for the fourth consecutive year.

Sera Prognostics, Inc. (NASDAQ:SERA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for SERA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for SERA spans 10-Q, 8-K, 424B5, 10-K.

Recent high-impact activity:

  • Sera Q3 10-Q: $42K Revenue, $72.8M Cash, $25.6M Nine-Month Net Loss
  • PreTRM Volume Jumps 54% Sequentially as Florida Medicaid Adds Coverage
  • Sera Prognostics Q2 Revenue Rises on Medicaid Mandate and New Partnerships
  • Sera Prognostics Q2 2026: Revenue Climbs 76% YoY, Cash Runway Extended to 2029
  • Sera Prognostics Appoints Former Myriad Genetics CEO Mark Capone to Board

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$81K
Net Income
-$31.93M
Diluted EPS
-$0.67
Op. Cash Flow
-$25.62M
Free Cash Flow
-$26.35M
Gross Profit
-$83K
Operating Income
-$36.5M
Cash & Equivalents
$3.94M
Debt / Equity
0.00×
Net Margin
-394.17×
Shares Outstanding
47.66M sh
Source: 10-K · filed 2026-03-18 · accession 0001534969-26-000009

Short Interest & Short Volume

9.12 days to cover

FINRA reported short interest of 219,751 shares in SERA as of the October 30, 2026 settlement, a 1.3% decrease from the prior period — about 9.1 days to cover at its recent average daily volume. On November 20, 2026, 26.2% of SERA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)219,751 shares as of October 30, 2026
Change vs prior period▼ 1.3%
Days to cover9.12 at avg daily volume of 24,089
Daily short volume (FINRA facilities)26.2% of 52,149 shares on November 20, 2026
5-day average short volume36.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$1.81
52-week range · as of 2026-11-04 $1.56 – $3.85
Market cap
$71.98M
Volume
94.6K (2.6× avg)
3-mo avg 36.8K
Live data · 2026-11-22 01:28 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SERA - Latest Insights

SERA
Nov 04, 2026, 4:14 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.02
Real-time Price: $1.81 info
Change: -$0.205 (-10%) info
Market Cap: $71.983M info
SERA
Nov 04, 2026, 4:05 PM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $2.02
Real-time Price: $1.81 info
Change: -$0.205 (-10%) info
Market Cap: $71.983M info
SERA
Aug 12, 2026, 4:28 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.02
Real-time Price: $1.81 info
Change: -$0.210 (-10%) info
Market Cap: $71.983M info
SERA
Aug 12, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.02
Real-time Price: $1.81 info
Change: -$0.210 (-10%) info
Market Cap: $71.983M info
SERA
Jun 30, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.82
Real-time Price: $1.81 info
Change: -$0.010 (-0.55%) info
Market Cap: $71.983M info
SERA
Jun 23, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $1.84
Real-time Price: $1.81 info
Change: -$0.030 (-2%) info
Market Cap: $71.983M info
SERA
May 06, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.72
Real-time Price: $1.81 info
Change: +$0.090 (+5%) info
Market Cap: $71.983M info
SERA
May 06, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.72
Real-time Price: $1.81 info
Change: +$0.090 (+5%) info
Market Cap: $71.983M info
SERA
May 06, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.72
Real-time Price: $1.81 info
Change: +$0.090 (+5%) info
Market Cap: $71.983M info
SERA
Mar 18, 2026, 4:48 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.86
Real-time Price: $1.81 info
Change: -$0.050 (-3%) info
Market Cap: $71.983M info
SERA
Mar 18, 2026, 4:08 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.89
Real-time Price: $1.81 info
Change: -$0.080 (-4%) info
Market Cap: $71.983M info
SERA
Mar 18, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.89
Real-time Price: $1.81 info
Change: -$0.080 (-4%) info
Market Cap: $71.983M info
SERA
Jan 08, 2026, 5:20 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.53
Real-time Price: $1.81 info
Change: -$1.72 (-49%) info
Market Cap: $71.983M info
SERA
Jan 07, 2026, 9:12 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.96
Real-time Price: $1.81 info
Change: -$1.15 (-39%) info
Market Cap: $71.983M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets